Table 3.
Shows the mean (SD) for the difference between baseline and sixth gestational week measurement for each marker in the two groups PL and LB, and p-values.
| EV Markers | PL (n = 6) | LB (n = 25) | p |
|---|---|---|---|
| AnnexinV | −5.1 (5.2) | −5.1 (14.8) | NS |
| CD9 | −3.2 (4.6) | 3.2 (7.6) | 0.04 |
| CD63 | −3.3 (7.4) | −1.4 (7) | NS |
| CD81 | −1.8 (4.3) | 0.2 (8.8) | NS |
| CD4 | 0.9 (2) | 0.2 (5.5) | NS |
| CD8 | −1 (4.5) | −0.5 (2.9) | NS |
| CD45 | −4.4 (9.6) | −1.9 (9.9) | NS |
| TRAIL | −2.8 (9.6) | −1.8 (9.6) | NS |
| HLA DR/DP/DQ | −4.6 (8.9) | −1.1 (7.3) | NS |
| HLA G | −2.6 (5.1) | −0.4 (5.7) | NS |
| FasLigand | −4 (9.3) | −5.7 (16.2) | NS |
| Hsp70 | 0.1 (5.2) | −1.5 (5.6) | NS |
| CD31 | −4.2 (5.9) | −3.6 (17) | NS |
| CD142 | −1.4 (5.9) | −1.8 (6.5) | NS |
| PLAP | −4.8 (6.4) | −2.6 (9.8) | NS |
| CAIX | −2.4 (9.9) | −3.7 (7.1) | NS |
| CAIXII | −5.1 (11.7) | −3.8 (13.2) | NS |
NS = nonsignificant.